期刊文献+

胱抑素C的临床应用及检测标准化进展 被引量:5

Clinical Application of Cystatin C and Its Detection Standardization Progress
下载PDF
导出
摘要 胱抑素C(Cys C)是一种反映肾小球滤过率的优良内源性标志物。此外,胱抑素C在预测心血管疾病、糖尿病肾病及先兆子痫方面也具有独特的优势。虽然检测胱抑素C的方法众多,但目前由于没有国际标准品,各个厂家的测定结果尚不具有可比性;国际临床化学和实验室医学联盟已经开始解决缺乏胱抑素C标准的问题,并于2010年制备了新的胱抑素C的国际标准品,目前为止,胱抑素C标准化还存在一定的问题,各方仍需共同努力来推进胱抑素C的标准化工作。 Cystatin C is an ideal endogenous marker for glomerular filtration rate.It also has unique advantages in predicting cardiovascular disease, diabetic nephropathy and preeclampsia disease.Although many assay methods were developed, there is still no international standard for Cystatin C.Therefore comparison studies are currently unavailable.IFCC has set out to solve this problem and the first Certified Reference Material for Cystatin C was release in 2010.Till now, there is still some problems in the standardization process, and more work should be done to promote the standardization process of Cystatin C.
作者 张小燕 杨宇
出处 《标记免疫分析与临床》 CAS 2017年第6期717-720,共4页 Labeled Immunoassays and Clinical Medicine
关键词 肾小球滤过率 标准化 胱抑素C Cystatin C glomerular filtration rate Standardization
  • 相关文献

参考文献1

二级参考文献24

  • 1Simonsen O,Grubb A,Thysell H.The blood serum concentration ofcystatinC(gamma-trace)as a measure of the glomerular filtrationrate[J].Scand J Clin Lab Invest,1985,45(2):97-101.
  • 2Rule AD,Berqstralh EJ,Slezak JM,et al.Glomerular filtration rateestimated by cystatin C among different clinical presentations[J].Kidney Int,2006,69(2):399-405.
  • 3胡志斌.血清半胱氨酸蛋白酶抑制剂C在早期肾损害诊断中的应用[J].临床血液学杂志:输血与检验版,2011,24(5):602-604.
  • 4Koenig W,Twardella D,Brenner H,et al.Plasma concentrations ofcystatin C in patients with coronary heart disease and risk forsecondary cardiovascular events:more than simply a marker ofglomerular filtration rate[J].Clin Chem,2005,51(2):321-327.
  • 5Clerico A,Fontana M,Zyw L,et al.Comparison of the diagnosticaccuracy of brain natriuretic peptide(BNP)and the N-terminal partof the propeptide of BNP immunoassays in chronic and acute heartfailure:a systematic review[J].Clin Chem,2007,53(5):813-822.
  • 6Taglieri N,Koenig W,Kaski JC.Cystatin C and cardiovsacular risk[J].Clin Chem,2009,55(11):1932-1943.
  • 7Matenzi G,Lauri G,Guazzi M,et al.Cardiac and renal dysfunctionin chronic heart failure:relation to neurohumoral activation andprognosis[J].Am J Med Sci,2001,321(6):359-366.
  • 8Shlipak MG,Sarnak MJ,Katz R,et al.Cystatin C and the risk ofdeath and cardiovascular events among elderly persons[J].N EnglJ Med,2005,352(20):2049-2060.
  • 9Reiber H.Dynamics of braind-derived proteins in cerebrospinalfluid[J].Clin Chim Acta,2001,310(2):173-186.
  • 10Domej W,Tilz GP,Fldes-Papp Z,et al.Cystain C of pleural effu-sion as a novel diagnostic aid in pleural diseases of different aeti-ologies[J].Clin Sci(Lond),2002,102(3):373-380.

共引文献15

同被引文献64

引证文献5

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部